Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Karuna Therapeutics Inc (KRTX)

Karuna Therapeutics Inc (KRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,877,207
  • Shares Outstanding, K 29,953
  • Annual Sales, $ 36,960 K
  • Annual Income, $ -143,810 K
  • 60-Month Beta 1.33
  • Price/Sales 182.27
  • Price/Cash Flow N/A
  • Price/Book 16.58
Trade KRTX with:

Options Overview Details

View History
  • Implied Volatility 64.24% ( -2.87%)
  • Historical Volatility 38.41%
  • IV Percentile 40%
  • IV Rank 9.78%
  • IV High 187.35% on 06/28/22
  • IV Low 50.88% on 10/28/21
  • Put/Call Vol Ratio 0.12
  • Today's Volume 95
  • Volume Avg (30-Day) 287
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 6,932
  • Open Int (30-Day) 13,185

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -2.01
  • Number of Estimates 8
  • High Estimate -1.51
  • Low Estimate -2.51
  • Prior Year -1.72
  • Growth Rate Est. (year over year) -16.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
216.75 +7.48%
on 09/26/22
259.61 -10.27%
on 09/09/22
-21.49 (-8.45%)
since 09/02/22
3-Month
122.59 +90.03%
on 08/02/22
278.25 -16.28%
on 08/12/22
+106.86 (+84.74%)
since 07/01/22
52-Week
92.26 +152.50%
on 05/12/22
278.25 -16.28%
on 08/12/22
+108.84 (+87.69%)
since 10/04/21

Most Recent Stories

More News
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?

Style Box ETF report for IWM

IWM : 174.82 (+3.27%)
IJR : 92.23 (+3.18%)
VB : 181.91 (+3.50%)
BHVN : 8.00 (-94.73%)
SWAV : 284.20 (+1.88%)
KRTX : 233.63 (+1.76%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 82.28 (+2.88%)
IBB : 122.23 (+2.51%)
CCXI : 51.84 (+0.04%)
GBT : 68.48 (unch)
FBT : 138.08 (+2.51%)
KRTX : 233.63 (+1.76%)
Why Is Karuna Therapeutics, Inc. (KRTX) Up 8.4% Since Last Earnings Report?

Karuna Therapeutics, Inc. (KRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

KRTX : 233.63 (+1.76%)
ISEE : 19.17 (+4.98%)
Karuna Therapeutics to Present at Upcoming Investor Conferences

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 233.63 (+1.76%)
PureTech Health plc – Half-Year Report

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its half-yearly results for the six months ended June 30, 2022. The following information will be filed...

PRTC : 27.00 (unch)
PRTC.LN : 245.500 (+4.47%)
AKLI : 2.47 (+2.71%)
GLS : 1.1100 (-1.77%)
DNAA : 14.07 (+47.02%)
RBLX : 38.44 (+5.58%)
CPSR : 7.36 (+9.85%)
KRTX : 233.63 (+1.76%)
VOR : 4.18 (+6.36%)
3 Biopharmas on Buyout Watch

These three biotech companies could be headed for a buyout soon.

PFE : 44.31 (+0.39%)
ALNY : 199.45 (+1.35%)
AXSM : 46.61 (+2.82%)
KRTX : 233.63 (+1.76%)
Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

Karuna Therapeutics, Inc. (NASDAQ: KRTX) (“Karuna”), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological...

KRTX : 233.63 (+1.76%)
Karuna (KRTX) Stock Skyrockets 98.7% in a Month: Here's Why

Karuna Therapeutics (KRTX) is progressing well with its pipeline development. KRTX's lead candidate meets late-stage study goals as a potential treatment for adults with schizophrenia.

GERN : 2.35 (-0.84%)
LLY : 328.79 (+2.25%)
MORF : 28.38 (+0.85%)
KRTX : 233.63 (+1.76%)
Karuna Therapeutics Announces Pricing of Public Offering of Common Stock

Karuna Therapeutics, Inc. (NASDAQ: KRTX) (“Karuna”), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological...

KRTX : 233.63 (+1.76%)
Karuna (KRTX) Lags on Q2 Earnings, Up 71% on Schizophrenia Data

Though Karuna's (KRTX) earnings miss estimates, KRTX's lead candidate meets late-stage study goals as a potential treatment for adults with schizophrenia.

GERN : 2.35 (-0.84%)
ALKS : 22.88 (-0.31%)
MORF : 28.38 (+0.85%)
KRTX : 233.63 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's product candidate consists of KarXT, for the treatment of acute...

See More

Key Turning Points

3rd Resistance Point 243.53
2nd Resistance Point 237.85
1st Resistance Point 233.73
Last Price 233.63
1st Support Level 223.93
2nd Support Level 218.25
3rd Support Level 214.13

See More

52-Week High 278.25
Last Price 233.63
Fibonacci 61.8% 207.20
Fibonacci 50% 185.26
Fibonacci 38.2% 163.31
52-Week Low 92.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar